Sorry to hear you have left Damo , maybe reconsider if the price...

Sorry to hear you have left Damo , maybe reconsider if the price stagnates during the deal. I think CP1 has more potential now than when it went into trading halt and AUsCann also has a product in market ,patent formulation, clinical data , R&D facilities and enough cash that CannPal can do a good deal rather than desperate deal or finish the job themselves.
Forget the AusCann historical bad performance it all started to change when Canopy dumped and Merchant bought .
Keep watching I sold down a little while back and now wish I hadn’t !!!!
DYOR